{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T16:00:47Z","timestamp":1772121647033,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Japanese Intractable Diseases Research Foundation","award":["2021B01"],"award-info":[{"award-number":["2021B01"]}]},{"DOI":"10.13039\/501100001691","name":"Japanese Society for the Promotion of Science KAKENHI","doi-asserted-by":"crossref","award":["19H03765"],"award-info":[{"award-number":["19H03765"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japanese Society for the Promotion of Science KAKENHI","doi-asserted-by":"crossref","award":["20K09362"],"award-info":[{"award-number":["20K09362"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosurg Rev"],"DOI":"10.1007\/s10143-025-03544-8","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T22:51:58Z","timestamp":1745535118000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association between intracranial vascular vulnerability and indirect revascularization development in moyamoya disease"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6567-8136","authenticated-orcid":false,"given":"Haruto","family":"Uchino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kota","family":"Kurisu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taku","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miki","family":"Fujimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,25]]},"reference":[{"key":"3544_CR1","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/archneur.1969.00480090076012","volume":"20","author":"J Suzuki","year":"1969","unstructured":"Suzuki J, Takaku A (1969) Cerebrovascular Moyamoya disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 20:288\u2013299. https:\/\/doi.org\/10.1001\/archneur.1969.00480090076012","journal-title":"Arch Neurol"},{"key":"3544_CR2","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2176\/nmc.ra.2014-0307","volume":"55","author":"M Fujimura","year":"2015","unstructured":"Fujimura M, Tominaga T (2015) Diagnosis of Moyamoya disease: international standard and regional differences. Neurol Med Chir (Tokyo) 55:189\u2013193. https:\/\/doi.org\/10.2176\/nmc.ra.2014-0307","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"3544_CR3","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2176\/jns-nmc.2021-0382","volume":"62","author":"M Fujimura","year":"2022","unstructured":"Fujimura M, Tominaga T, Kuroda S et al (2022) 2021 Japanese guidelines for the management of Moyamoya disease: guidelines from the research committee on Moyamoya disease and Japan stroke society. Neurol Med Chir (Tokyo) 62:165\u2013170. https:\/\/doi.org\/10.2176\/jns-nmc.2021-0382","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"3544_CR4","doi-asserted-by":"publisher","first-page":"796","DOI":"10.2176\/nmc.oa.2015-0044","volume":"55","author":"S Kuroda","year":"2015","unstructured":"Kuroda S, Kashiwazaki D, Akioka N et al (2015) Specific shrinkage of carotid forks in Moyamoya disease: A novel key finding for diagnosis. Neurol Med Chir (Tokyo) 55:796\u2013804. https:\/\/doi.org\/10.2176\/nmc.oa.2015-0044","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"3544_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2176\/nmc.42.11","volume":"42","author":"M Komiyama","year":"2002","unstructured":"Komiyama M, Ishiguro T, Nishikawa M, Yasui T, Morikawa T, Kitano S, Sakamoto H (2002) Constructive interference in steady state imaging of Moyamoya disease. Neurol Med Chir (Tokyo) 42:11\u201316 discussion 17. https:\/\/doi.org\/10.2176\/nmc.42.11","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"3544_CR6","doi-asserted-by":"publisher","first-page":"e661","DOI":"10.1016\/j.wneu.2019.02.120","volume":"126","author":"S Yamamoto","year":"2019","unstructured":"Yamamoto S, Kashiwazaki D, Uchino H et al (2019) Stenosis Severity-Dependent shrinkage of posterior cerebral artery in Moyamoya disease. World Neurosurg 126:e661\u2013e670. https:\/\/doi.org\/10.1016\/j.wneu.2019.02.120","journal-title":"World Neurosurg"},{"key":"3544_CR7","doi-asserted-by":"publisher","first-page":"e253","DOI":"10.1016\/j.wneu.2018.10.001","volume":"122","author":"S Yamamoto","year":"2019","unstructured":"Yamamoto S, Kashiwazaki D, Akioka N, Kuwayama N, Noguchi K, Kuroda S (2019) Progressive shrinkage of involved arteries in parallel with disease progression in Moyamoya disease. World Neurosurg 122:e253\u2013e261. https:\/\/doi.org\/10.1016\/j.wneu.2018.10.001","journal-title":"World Neurosurg"},{"key":"3544_CR8","doi-asserted-by":"publisher","first-page":"307","DOI":"10.2176\/jns-nmc.2022-0072","volume":"62","author":"S Kuroda","year":"2022","unstructured":"Kuroda S, Fujimura M, Takahashi J et al (2022) Diagnostic criteria for Moyamoya disease\u2013\u20092021 revised version. Neurol Med Chir (Tokyo) 62:307\u2013312. https:\/\/doi.org\/10.2176\/jns-nmc.2022-0072","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"3544_CR9","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s10143-023-02030-3","volume":"46","author":"H Uchino","year":"2023","unstructured":"Uchino H, Ito M, Tokairin K, Tatezawa R, Sugiyama T, Kazumata K, Fujimura M (2023) Association of RNF213 polymorphism and cortical hyperintensity sign on fluid-attenuated inversion recovery images after revascularization surgery for Moyamoya disease: possible involvement of intrinsic vascular vulnerability. Neurosurg Rev 46:119. https:\/\/doi.org\/10.1007\/s10143-023-02030-3","journal-title":"Neurosurg Rev"},{"key":"3544_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2015.10.JNS151022","volume":"126","author":"E Hamano","year":"2017","unstructured":"Hamano E, Kataoka H, Morita N, Maruyama D, Satow T, Iihara K, Takahashi JC (2017) Clinical implications of the cortical hyperintensity belt sign in fluid-attenuated inversion recovery images after bypass surgery for Moyamoya disease. J Neurosurg 126:1\u20137. https:\/\/doi.org\/10.3171\/2015.10.JNS151022","journal-title":"J Neurosurg"},{"key":"3544_CR11","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1161\/STROKEAHA.114.004755","volume":"45","author":"N Horie","year":"2014","unstructured":"Horie N, Morikawa M, Morofuji Y, Hiu T, Izumo T, Hayashi K, Nagata I (2014) De Novo Ivy sign indicates postoperative hyperperfusion in Moyamoya disease. Stroke 45:1488\u20131491. https:\/\/doi.org\/10.1161\/STROKEAHA.114.004755","journal-title":"Stroke"},{"key":"3544_CR12","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jocn.2020.02.022","volume":"74","author":"Y Takemoto","year":"2020","unstructured":"Takemoto Y, Kawano T, Ohmori Y et al (2020) Hemodynamic study about cortical hyperintensity belt sign after direct bypass surgery for Moyamoya disease. J Clin Neurosci 74:124\u2013129. https:\/\/doi.org\/10.1016\/j.jocn.2020.02.022","journal-title":"J Clin Neurosci"},{"key":"3544_CR13","doi-asserted-by":"publisher","unstructured":"Uchino H, Yamamoto S, Kashiwazaki D, Akioka N, Kuwayama N, Noguchi K, Kuroda S (2019) Using postoperative remodeling of donor arteries on MR angiography to predict the development of surgical collaterals in Moyamoya disease. J Neurosurg 1\u20139. https:\/\/doi.org\/10.3171\/2019.8.JNS191846","DOI":"10.3171\/2019.8.JNS191846"},{"key":"3544_CR14","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1227\/NEU.0000000000001201","volume":"80","author":"H Uchino","year":"2017","unstructured":"Uchino H, Kim JH, Fujima N et al (2017) Synergistic interactions between direct and indirect bypasses in combined procedures: the significance of indirect bypasses in Moyamoya disease. Neurosurgery 80:201\u2013209. https:\/\/doi.org\/10.1227\/NEU.0000000000001201","journal-title":"Neurosurgery"},{"key":"3544_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.5853\/jos.2014.16.2.65","volume":"16","author":"M Fujimura","year":"2014","unstructured":"Fujimura M, Sonobe S, Nishijima Y, Niizuma K, Sakata H, Kure S, Tominaga T (2014) Genetics and biomarkers of Moyamoya disease: significance of RNF213 as a susceptibility gene. J Stroke 16:65\u201372. https:\/\/doi.org\/10.5853\/jos.2014.16.2.65","journal-title":"J Stroke"},{"key":"3544_CR16","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1159\/000526089","volume":"52","author":"M Kawabori","year":"2023","unstructured":"Kawabori M, Ito M, Kazumata K et al (2023) Impact of RNF213 c.14576G\u2009>\u2009A variant on the development of direct and indirect revascularization in pediatric Moyamoya disease. Cerebrovasc Dis 52:171\u2013176. https:\/\/doi.org\/10.1159\/000526089","journal-title":"Cerebrovasc Dis"},{"key":"3544_CR17","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1007\/s10143-022-01749-9","volume":"45","author":"M Ito","year":"2022","unstructured":"Ito M, Kawabori M, Sugiyama T et al (2022) Impact of RNF213 founder polymorphism (p.R4810K) on the postoperative development of indirect Pial synangiosis after direct\/indirect combined revascularization surgery for adult Moyamoya disease. Neurosurg Rev 45:2305\u20132313. https:\/\/doi.org\/10.1007\/s10143-022-01749-9","journal-title":"Neurosurg Rev"},{"key":"3544_CR18","doi-asserted-by":"crossref","unstructured":"Uchino HIM, Sugiyama T, Kurisu K, Fujima N, Fujimura M (2025) Association between RNF213 p.R4810K and progression of cerebral artery negative remodeling in Moyamoya disease. Neurol Med Chir (Tokyo","DOI":"10.2176\/jns-nmc.2025-0019"},{"key":"3544_CR19","doi-asserted-by":"publisher","first-page":"327","DOI":"10.2176\/nmc.52.327","volume":"52","author":"M Fujimura","year":"2012","unstructured":"Fujimura M, Tominaga T (2012) Lessons learned from Moyamoya disease: outcome of direct\/indirect revascularization surgery for 150 affected hemispheres. Neurol Med Chir (Tokyo) 52:327\u2013332. https:\/\/doi.org\/10.2176\/nmc.52.327","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"3544_CR20","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.surneu.2006.07.017","volume":"67","author":"M Fujimura","year":"2007","unstructured":"Fujimura M, Kaneta T, Mugikura S, Shimizu H, Tominaga T (2007) Temporary neurologic deterioration due to cerebral hyperperfusion after superficial Temporal artery-middle cerebral artery anastomosis in patients with adult-onset Moyamoya disease. Surg Neurol 67:273\u2013282. https:\/\/doi.org\/10.1016\/j.surneu.2006.07.017","journal-title":"Surg Neurol"},{"key":"3544_CR21","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1161\/STROKEAHA.112.654723","volume":"43","author":"H Uchino","year":"2012","unstructured":"Uchino H, Kuroda S, Hirata K, Shiga T, Houkin K, Tamaki N (2012) Predictors and clinical features of postoperative hyperperfusion after surgical revascularization for Moyamoya disease: a serial single photon emission CT\/positron emission tomography study. Stroke 43:2610\u20132616. https:\/\/doi.org\/10.1161\/STROKEAHA.112.654723","journal-title":"Stroke"},{"key":"3544_CR22","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1007\/s00701-012-1472-4","volume":"154","author":"Y Kaku","year":"2012","unstructured":"Kaku Y, Morioka M, Ohmori Y et al (2012) Outer-diameter narrowing of the internal carotid and middle cerebral arteries in Moyamoya disease detected on 3D constructive interference in steady-state MR image: is arterial constrictive remodeling a major pathogenesis? Acta Neurochir (Wien) 154:2151\u20132157. https:\/\/doi.org\/10.1007\/s00701-012-1472-4","journal-title":"Acta Neurochir (Wien)"},{"key":"3544_CR23","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1161\/STROKEAHA.114.004761","volume":"45","author":"S Ryoo","year":"2014","unstructured":"Ryoo S, Cha J, Kim SJ et al (2014) High-resolution magnetic resonance wall imaging findings of Moyamoya disease. Stroke 45:2457\u20132460. https:\/\/doi.org\/10.1161\/STROKEAHA.114.004761","journal-title":"Stroke"},{"key":"3544_CR24","doi-asserted-by":"publisher","unstructured":"Fukui M, Kono S, Sueishi K, Ikezaki K (2000) Moyamoya disease. https:\/\/doi.org\/10.1046\/j.1440-1789.2000.00300.x. Neuropathology 20 Suppl:S61-64","DOI":"10.1046\/j.1440-1789.2000.00300.x"},{"key":"3544_CR25","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/S1474-4422(08)70240-0","volume":"7","author":"S Kuroda","year":"2008","unstructured":"Kuroda S, Houkin K (2008) Moyamoya disease: current concepts and future perspectives. Lancet Neurol 7:1056\u20131066. https:\/\/doi.org\/10.1016\/S1474-4422(08)70240-0","journal-title":"Lancet Neurol"},{"key":"3544_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2176\/nmc.47.1","volume":"47","author":"Y Takagi","year":"2007","unstructured":"Takagi Y, Kikuta K, Nozaki K, Hashimoto N (2007) Histological features of middle cerebral arteries from patients treated for Moyamoya disease. Neurol Med Chir (Tokyo) 47:1\u20134. https:\/\/doi.org\/10.2176\/nmc.47.1","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"3544_CR27","doi-asserted-by":"publisher","first-page":"345","DOI":"10.2176\/nmc.oa.2016-0031","volume":"56","author":"Y Takagi","year":"2016","unstructured":"Takagi Y, Hermanto Y, Takahashi JC et al (2016) Histopathological characteristics of distal middle cerebral artery in adult and pediatric patients with Moyamoya disease. Neurol Med Chir (Tokyo) 56:345\u2013349. https:\/\/doi.org\/10.2176\/nmc.oa.2016-0031","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"3544_CR28","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1136\/jnnp.2009.191817","volume":"81","author":"HS Kang","year":"2010","unstructured":"Kang HS, Kim JH, Phi JH et al (2010) Plasma matrix metalloproteinases, cytokines and angiogenic factors in Moyamoya disease. J Neurol Neurosurg Psychiatry 81:673\u2013678. https:\/\/doi.org\/10.1136\/jnnp.2009.191817","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3544_CR29","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.surneu.2008.10.009","volume":"72","author":"M Fujimura","year":"2009","unstructured":"Fujimura M, Watanabe M, Narisawa A, Shimizu H, Tominaga T (2009) Increased expression of serum matrix Metalloproteinase-9 in patients with Moyamoya disease. Surg Neurol 72:476\u2013480 discussion 480. https:\/\/doi.org\/10.1016\/j.surneu.2008.10.009","journal-title":"Surg Neurol"},{"key":"3544_CR30","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s00701-019-03811-w","volume":"161","author":"A Narducci","year":"2019","unstructured":"Narducci A, Yasuyuki K, Onken J, Blecharz K, Vajkoczy P (2019) In vivo demonstration of blood-brain barrier impairment in Moyamoya disease. Acta Neurochir (Wien) 161:371\u2013378. https:\/\/doi.org\/10.1007\/s00701-019-03811-w","journal-title":"Acta Neurochir (Wien)"},{"key":"3544_CR31","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.bbrc.2013.07.004","volume":"438","author":"T Hitomi","year":"2013","unstructured":"Hitomi T, Habu T, Kobayashi H et al (2013) Downregulation of securin by the variant RNF213 R4810K (rs112735431, G\u2009>\u2009A) reduces angiogenic activity of induced pluripotent stem cell-derived vascular endothelial cells from Moyamoya patients. Biochem Biophys Res Commun 438:13\u201319. https:\/\/doi.org\/10.1016\/j.bbrc.2013.07.004","journal-title":"Biochem Biophys Res Commun"},{"key":"3544_CR32","doi-asserted-by":"publisher","first-page":"e0163561","DOI":"10.1371\/journal.pone.0163561","volume":"11","author":"S Hamauchi","year":"2016","unstructured":"Hamauchi S, Shichinohe H, Uchino H et al (2016) Cellular functions and gene and protein expression profiles in endothelial cells derived from Moyamoya Disease-Specific iPS cells. PLoS ONE 11:e0163561. https:\/\/doi.org\/10.1371\/journal.pone.0163561","journal-title":"PLoS ONE"},{"key":"3544_CR33","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1227\/NEU.0b013e318208f1da","volume":"68","author":"M Fujimura","year":"2011","unstructured":"Fujimura M, Shimizu H, Inoue T, Mugikura S, Saito A, Tominaga T (2011) Significance of focal cerebral hyperperfusion as a cause of transient neurologic deterioration after extracranial-intracranial bypass for Moyamoya disease: comparative study with non-moyamoya patients using N-isopropyl-p-[(123)I]iodoamphetamine single-photon emission computed tomography. Neurosurgery 68:957\u2013964 discussion 964\u2013\u2009955. https:\/\/doi.org\/10.1227\/NEU.0b013e318208f1da","journal-title":"Neurosurgery"},{"key":"3544_CR34","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1007\/s10143-020-01395-z","volume":"44","author":"M Katsuki","year":"2021","unstructured":"Katsuki M, Fujimura M, Tashiro R, Tomata Y, Nishizawa T, Tominaga T (2021) Pre-operative higher hematocrit and lower total protein levels are independent risk factors for cerebral hyperperfusion syndrome after superficial Temporal artery-middle cerebral artery anastomosis with Pial synangiosis in adult Moyamoya disease patients-case-control study. Neurosurg Rev 44:2191\u20132200. https:\/\/doi.org\/10.1007\/s10143-020-01395-z","journal-title":"Neurosurg Rev"},{"key":"3544_CR35","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.3171\/2020.3.JNS193273","volume":"134","author":"T Hayashi","year":"2021","unstructured":"Hayashi T, Yamamoto S, Hamashima T, Mori H, Sasahara M, Kuroda S (2021) Critical role of platelet-derived growth factor-alpha in angiogenesis after indirect bypass in a murine Moyamoya disease model. J Neurosurg 134:1535\u20131543. https:\/\/doi.org\/10.3171\/2020.3.JNS193273","journal-title":"J Neurosurg"},{"key":"3544_CR36","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3171\/2008.6.PEDS0834","volume":"3","author":"M Nakamura","year":"2009","unstructured":"Nakamura M, Imai H, Konno K et al (2009) Experimental investigation of encephalomyosynangiosis using gyrencephalic brain of the miniature pig: histopathological evaluation of dynamic reconstruction of vessels for functional anastomosis. Laboratory investigation. J Neurosurg Pediatr 3:488\u2013495. https:\/\/doi.org\/10.3171\/2008.6.PEDS0834","journal-title":"J Neurosurg Pediatr"},{"key":"3544_CR37","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.2174\/1570159X18666200720173316","volume":"18","author":"Y Yang","year":"2020","unstructured":"Yang Y, Torbey MT (2020) Angiogenesis and Blood-Brain barrier permeability in vascular remodeling after stroke. Curr Neuropharmacol 18:1250\u20131265. https:\/\/doi.org\/10.2174\/1570159X18666200720173316","journal-title":"Curr Neuropharmacol"},{"key":"3544_CR38","doi-asserted-by":"publisher","first-page":"882","DOI":"10.3171\/jns.2005.103.5.0882","volume":"103","author":"N Kusaka","year":"2005","unstructured":"Kusaka N, Sugiu K, Tokunaga K et al (2005) Enhanced brain angiogenesis in chronic cerebral hypoperfusion after administration of plasmid human vascular endothelial growth factor in combination with indirect vasoreconstructive surgery. J Neurosurg 103:882\u2013890. https:\/\/doi.org\/10.3171\/jns.2005.103.5.0882","journal-title":"J Neurosurg"},{"key":"3544_CR39","doi-asserted-by":"publisher","first-page":"679","DOI":"10.3171\/2016.8.JNS16366","volume":"127","author":"M Hiramatsu","year":"2017","unstructured":"Hiramatsu M, Hishikawa T, Tokunaga K et al (2017) Combined gene therapy with vascular endothelial growth factor plus Apelin in a chronic cerebral hypoperfusion model in rats. J Neurosurg 127:679\u2013686. https:\/\/doi.org\/10.3171\/2016.8.JNS16366","journal-title":"J Neurosurg"}],"container-title":["Neurosurgical Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-025-03544-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10143-025-03544-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-025-03544-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:02:31Z","timestamp":1772118151000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10143-025-03544-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,25]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3544"],"URL":"https:\/\/doi.org\/10.1007\/s10143-025-03544-8","relation":{},"ISSN":["1437-2320"],"issn-type":[{"value":"1437-2320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,25]]},"assertion":[{"value":"21 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by an Institutional Review Board at Hokkaido University Hospital (approval number 024\u20130257).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"387"}}